ALEMBIC PHARMA at All Time High; BSE HEALTHCARE Index Up 1.2%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  •
  • MyStocks
MEMBER'S LOGIN

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA at All Time High; BSE HEALTHCARE Index Up 1.2%
Fri, 24 Apr 12:02 PM

ALEMBIC PHARMA share price has hit an all-time high at Rs 808 (up 12.6%).

Meanwhile, the BSE HEALTHCARE Index is at 15,402 (up 1.2%).

Among the top gainers in the BSE HEALTHCARE Index today are ALEMBIC PHARMA (up 12.6%) and SANOFI INDIA (up 1.9%).

PFIZER (down 0.1%) and ABBOTT INDIA (down 0.2%) are among the top losers today.

Over the last one year, ALEMBIC PHARMA has moved up from Rs 544 to Rs 808, registering a gain of Rs 263 (up 44.5%).

The BSE HEALTHCARE has moved up from 14,413 to 15,402, registering a gain of 989 points (up 6.7%) during the last 12 months.

The top gainers among the BSE HEALTHCARE Index stocks during this same period were ABBOTT INDIA (up 110.5%), IPCA LABS (up 62.6%) and FDC LTD. (up 61.6%).

REVEALED: The Secret to potentially Making Rs 18,870, Rs 9,425 and Rs 7,315 in a Single Day...

What About the Benchmark Indices?

The BSE Sensex is at 31,545 (down 1.1%). The top gainers among the BSE Sensex stocks today are RELIANCE IND. (up 3.4%), ONGC (up 2.4%) and HERO MOTOCORP (up 2.3%). Other gainers include NESTLE (up 1.7%) and SUN PHARMA (up 1.5%). The most traded stocks in the BSE Sensex are RELIANCE IND. and ONGC.

In the meantime, NSE Nifty is at 9,228 (down 1.2%). The top gainers in the NSE Nifty include RELIANCE IND. (up 3.8%), HERO MOTOCORP (up 2.3%) and VEDANTA LTD (up 2.3%). Other gainers include ONGC (up 2.1%) and BRITANNIA (up 2.0%).

Over the last 12 months, the BSE Sensex has moved down from 38,565 to 31,545, registering a loss of 7,020 points (down 18.3%).

ALEMBIC PHARMA Financial Update...

ALEMBIC PHARMA net profit stood at Rs 2 billion for the quarter ended December 2019, compared to a profit of Rs 2 billion a year ago. Net Sales rose 18.8% to Rs 12.1 billion during the period as against Rs 10.2 billion in October-December 2018.

For the year ended March 2019, ALEMBIC PHARMA reported 40.8% increase in net profit to Rs 5.9 billion compared to net profit of Rs 4.2 billion during FY18.

Revenue of the company grew 25.7% to Rs 39 billion during FY19.

The current Price to earnings ratio of ALEMBIC PHARMA, based on rolling 12 month earnings, stands at 20.2x.

Archives

RSS RSS



What else is happening in the markets today? Dig in...

Equitymaster requests your view! Post a comment on "ALEMBIC PHARMA at All Time High; BSE HEALTHCARE Index Up 1.2%". Click here!

  

Stock Market Updates

Mutual Fund Buying Activity in February, Easy Trip Planners IPO, and Buzzing Stocks Today (Today's Market)

Mar 9, 2021 Pre-Open

Indian share markets ended their day on a flat note yesterday. At the closing bell yesterday, the BSE Sensex stood higher by 35 points (up 0.1%).

Indian Indices End Flat, GAIL and UPL Among Top Nifty Gainers (Today's Market)

Mar 8, 2021 Closing

Indian share markets end on a flat note with the Sensex ending up by 35 points and the Nifty ending up by 18 points.

Sensex Trades Over 200 Points Higher; Dow Futures Up by 37 Points (Today's Market)

Mar 8, 2021 12:30 pm

BSE Sensex is trading up by 214 points, while the NSE Nifty is trading up by 76 points.

Indian Share Markets Open Higher; GAIL & ONGC Surge 5% (Today's Market)

Mar 8, 2021 09:30 am

Indian share markets open higher. The BSE Sensex opened up by 363 points, while the Nifty is trading higher by 112 points.

ONGC at 52 Week High; BSE 500 Index Up 1.0% (Today's Market)

Mar 8, 2021 09:40 AM

ONGC share price has hit a 52-week high. It is presently trading at Rs 121. BSE 500 Index is up by 0.7% at 20,123. Within the BSE 500, ONGC (up 5.2%) and BEML (up 13.1%) are among the top gainers, while top losers are DHFL and CORPORATION BANK.

GRINDWELL NORTON at 52 Week High; BSE 500 Index Up 1.0% (Today's Market)

Mar 8, 2021 09:38 AM

GRINDWELL NORTON share price has hit a 52-week high. It is presently trading at Rs 975. BSE 500 Index is up by 0.8% at 20,123. Within the BSE 500, GRINDWELL NORTON (up 5.5%) and BEML (up 11.8%) are among the top gainers, while top losers are DHFL and CORPORATION BANK.

View More Indian Share Market News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps(Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Make Rs 5,000 Per Day Trading the Market(Fast Profits Daily)

Feb 25, 2021

In this video, I'll show you how to get started on the path to daily trading profits.

Charge Your Portfolio with this Smallcap Proxy Play on India's EV Revolution(Profit Hunter)

Mar 5, 2021

This could be the biggest wealth creator of the decade.

Gold 65,000 and Silver 84,000 in 2022

Feb 26, 2021

In this episode of the Investor Hour, India's #1 trader, Vijay Bhambwani, talks to us about the stock market, his new targets for gold and silver, the best long-term investment opportunity, and a lot more.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Report: Multibagger Stock Ideas 2021
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

S&P BSE SENSEX


Mar 8, 2021 (Close)

FEATURED VIDEOS

A Time Correction in the Nifty

The Best Stocks in a Volatile Market

Gold 65,000 and Silver 84,000 in 2022

How Long Before a Big Stock Market Crash

More Featured Videos

MARKET STATS


ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

FREE NEWSLETTERS
PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
FOLLOW
  • Follow on YouTube
  • Follow on LinkedIn Follow @Equitymaster Follow on RSS Follow on Telegram

APP
  • Get Equitymaster Android App on Google Play

Copyright © Equitymaster Agora Research Private Limited.

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Equitymaster Agora Research Private Limited (Research Analyst) 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.

SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.